SEARCH
Kiran Mazumdar of Biocon on launch of insulin glargine
CNBC-TV18
2019-09-03
Views
22
Description
Share / Embed
Download This Video
Report
The US FDA has issued a complete response letter for insulin glargine. Kiran Mazumdar Shaw, CMD of Biocon spoke at length about the response letter.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x7jwwvd" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
04:17
Kiran Mazumdar Shaw Chairman of Biocon India
06:34
Kiran Mazumdar : Pfizer and Biocon have amicable separation
01:31
Interview: Biocon MD, Kiran Mazumdar Shaw
11:29
Allow companies to provide booster doses to employees: Biocon chief Kiran Mazumdar-Shaw | EXCLUSIVE
14:54
Kiran Mazumdar-Shaw: Australia, New Zealand & Europe Will Be Strong Markets For Biocon
08:46
Kiran Mazumdar Shaw of Biocon on biosimilar & business outlook
00:53
Covid-19 | A message from Biocon chief Kiran Mazumdar Shaw
02:05
Biocon chief Kiran Mazumdar Shaw questions govt's Covid vaccine policy
22:04
Don't think the budget has moved the needle in improving consumption, says Kiran Mazumdar Shaw of Biocon
03:55
ಕರ್ನಾಟಕದ ಬಯೋಕಾನ್ನಲ್ಲಿ ಸಿದ್ದವಾಗ್ತಿದೆ ವ್ಯಾಕ್ಸಿನ್ | Biocon | Kiran Mazumdar Shaw | TV5 Kannada
04:14
Catch Kiran Mazumdar Shaw - CMD of Biocon in an exclusive conversation with ET NOW as she speaks about Rajan returning to academia.
10:25
Kiran Mazumdar Shaw of Biocon on business outlook
